Overjet just became your scribe’s competition

Last Updated: March 10, 2026

Welcome to this week’s Dental AI Weekly, honest analysis of where dental AI is going, from someone building in it.

I started Dental AI Weekly because I kept noticing a gap, the dental AI conversation was happening in DSO boardrooms and trade press, but not with the people who actually see patients. Whether you run your own practice or you’re a clinician inside a group, the enterprise headlines rarely tell you what it actually means for your chair, your workflow, or your patients. So every week I put together what I’m tracking, what I think it means, and what practicing clinicians should actually pay attention to.

This week is a good one to start with.

🚨 Overjet acquired a voice scribe startup in December, announced a 216-location rollout of its Voice product with a US DSO, and in February signed what it calls the largest dental AI rollout in UK dentistry, all within 90 days.

When an imaging company acquires a scribe startup and lines up a 216-location rollout within weeks, they’re not shipping a feature. They’re declaring what kind of company they want to be. Overjet is building a full-stack platform, and it happened faster than almost anyone in the industry noticed.

What I’m tracking this week:

• Overjet’s 90-day pivot: The DentalBee acquisition, a 216-location Overjet Voice rollout with North American Dental Group, and the mydentist UK deal, all sequenced in a single quarter. In January, Vision Dental Partners also named Overjet its exclusive AI partner across its nine Indiana locations. A sequence that fast suggests the roadmap was planned before the deal closed.

• Pearl is moving too: PDS Health named Pearl its enterprise AI partner in February, bringing real-time radiologic support to its practices. Two of the biggest dental AI players simultaneously locking up large groups. The enterprise end of the market is getting cornered.

• Nobody is talking about accuracy: As Overjet Voice and Bola AI push mass adoption, the accuracy conversation is conspicuously absent. AI-generated notes with wrong tooth numbers or missed allergy entries create real liability. The rush to market hasn’t been matched by transparency about where these tools fail.

• The signal hiding in the noise: Most of the dental AI conversation is happening in DSO boardrooms and trade press, not with the individual clinicians delivering care every day.

Here’s what I think is actually happening.

Overjet, Pearl, and the enterprise players are smart. They’ve identified where the money moves fastest: large groups, single procurement decision, rapid rollout across hundreds of locations. That’s a real business. But it’s a fundamentally different business than building tools that work for the individual clinician.

The tools getting deployed in DSOs right now were selected by procurement teams optimizing for contract terms and rollout speed, not for whether the tool actually makes a hygienist’s 45-minute recall appointment run better, or whether a dentist feels confident the note it generates is accurate enough to sign.

That gap matters whether you’re running an independent practice or you’re a clinician inside a group. Independent practitioners aren’t Overjet’s target market. And DSO clinicians may find that what their organization bought wasn’t really chosen with them in mind. At OraCore, we’re building the other thing, AI documentation designed around the clinical workflow of the full care team. No enterprise contract required. No IT implementation. Works with the practice management software you already use. Built so every member of the care team, dentist, hygienist, assistant, has tools that work for them specifically, not just the dentist the procurement team thought about. Less time on documentation means more presence with the patient. That’s the goal.

When your organization or colleagues evaluate AI scribe tools, who’s actually in the room making that decision?

Hit reply, I read every one and respond when I can.

Until next week,

Brad Hutchison

CEO, OraCore AI

oracoreai.com · LinkedIn